The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 341:1475-1476 November 4, 1999 Number 19
NextNext

A Serologic Marker of Paraneoplastic Limbic and Brain-Stem Encephalitis in Patients with Testicular Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Voltz, R.
-PubMed Citation
To the Editor: Voltz et al. (June 10 issue)1 report finding antibodies against a new neuronal antigen (Ma2) in paraneoplastic limbic and brain-stem encephalitis associated with testicular cancer. They suggest that "patients with symptoms of paraneoplastic limbic or brain-stem encephalitis, particularly if they are young men, should be examined for serum antibodies against Ma2. Detection of these antibodies supports the diagnosis of a paraneoplastic syndrome and guides the search for the tumor to the testis." We disagree.

The authors cite epidemiologic evidence that 80 percent of patients with paraneoplastic limbic encephalitis have small-cell lung cancer. In the remaining 20 percent, . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.